A major international study published today in BMJ Public Health has found that a digitally enabled healthcare programme was associated with significant improvements in blood pressure control among people living with hypertension across sub-Saharan Africa.
The OpenBind consortium\u2019s first release of experimental data marks a milestone in efforts to improve how artificial intelligence (AI) is used in drug discovery.
Professor Andrew Sharott (Team leader) and Professor Laura Parkkinen (Co-Investigator) from Nuffield Department of Clinical Neurosciences (NDCN) have been selected for multi-year grants to join the Collaborative Research Network (CRN) an international, multidisciplinary, multi-institutional network working to address high-priority research questions about Parkinson's disease.
The Nuffield Department of Women's & Reproductive Health is proud to announce that it is now leading Tommy's National Centre for Miscarriage Research, alongside existing partners: the University of Birmingham, the University of Warwick, and Imperial College London.
The European Patent Office has announced that Professor Adrian Hill, Lakshmi Mittal Professor of Vaccinology and Director of the Jenner Institute at Oxford University, is one of three finalists in the \u2018Research\u2019 category of the European Inventor Award for his development of a vaccine against Malaria.
Researchers from the University of Oxford, the Stowers Institute for Medical Research, Helmholtz Munich, and the Technical University of Munich have developed a new artificial intelligence framework that helps uncover how cells make developmental decisions.
A large international study led by researchers at the University of Oxford and the University of Virginia (USA) has identified a new model for predicting outcomes for hypertrophic cardiomyopathy (HCM) \u2013 a heart condition that is the most frequent cause of sudden cardiac death in younger individuals.
Researchers from the Department of Oncology in collaboration with the Department of Chemistry have developed a promising new compound designed to reduce tumour hypoxia, a major cause of radiotherapy resistance.
Two students from the University of Oxford\u2019s MSc in Global Healthcare Leadership programme, jointly delivered by the Nuffield Department of Primary Care Health Sciences (NDPCHS) and Sa\u00efd Business School, have co-founded a new social enterprise called \u2018Synergya\u2019, designed to help health and sustainability ventures scale through structured collaboration.
On World Ovarian Cancer Day, we recognise the impact ovarian cancer has on women and families worldwide, and the urgent need for earlier diagnosis, improved treatment, and better survival outcomes. The day also highlights the importance of continued research to improve understanding of ovarian cancer biology, diagnosis, treatment, and patient outcomes.
A new study published in Nature Medicine suggests that simple, low-cost tools could help health workers identify children at risk of life-threatening infection earlier, improving access to urgent care in across South and South East Asia.
A major new NIHR funded programme grant aims to make medical implants safer and better value for money in the NHS. The project will develop a robust framework to assess the long-term risks, benefits and costs of implants.
A team from the University of Oxford and Oxford Health NHS Foundation Trust created a therapeutic horticulture garden in a psychiatric intensive care unit for young people, as part of a new study looking at how green spaces can benefit patients and staff.
A Phase II Study, published in The Lancet Obstetrics, Gynaecology & Women's Health, highlights the potential of a new molecular imaging agent, \u201899mTc-maraciclatide\u2019, when used alongside a non-invasive scan to diagnose and monitor the development and treatment of Endometriosis.
A new study by Tommy\u2019s researchers, led by Professor Arri Coomarasamy, from the Nuffield Department of Women\u2019s & Reproductive Health, suggests that offering follow-up care from the first miscarriage could help prevent around 10,000 pregnancy losses each year in the UK.
A new clinical trial led by researchers at the Jenner Institute in collaboration Ifakara Health Institute Tanzania, suggests that a single-dose rabies vaccine could provide safe, long-lasting protection in both adults and children. The research could lead to a simpler, lower-cost approach that could transform rabies prevention in high-risk regions.
![\"Two](\"https://www.medsci.ox.ac.uk/news/major-study-highlights-promise-of-digital-technology-in-improving-hypertension-care-across-sub-saharan-africa/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n